Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.04K Hold
68
﹤0.01% 719
2026
Q1
$8.13K Hold
68
﹤0.01% 686
2025
Q4
$9.26K Hold
68
﹤0.01% 667
2025
Q3
$10K Hold
68
﹤0.01% 627
2025
Q2
$8.8K Sell
68
-18
-21% -$2.18K ﹤0.01% 500
2025
Q1
$10.3K Hold
86
﹤0.01% 510
2024
Q4
$9.98K Hold
86
﹤0.01% 510
2024
Q3
$11.6K Buy
+86
New +$11.5K ﹤0.01% 498
2023
Q3
Sell
-62
Closed -$6.98K 651
2023
Q2
$6.98K Buy
+62
New +$6.56K ﹤0.01% 514
2016
Q3
Sell
-200
Closed -$9K 664
2016
Q2
$9K Buy
+200
New +$8.69K ﹤0.01% 439

Other funds holding XYL

Oakworth Capital's XYL Position: Q2 2026 in Review

Oakworth Capital held its Xylem (XYL) position steady in Q2 2026 at 68 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

Oakworth Capital first reported a position in XYL in Q2 2016 and has held it in 10 quarters since. The position peaked at $11.6K in Q3 2024. 274 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Oakworth Capital held 68 shares of Xylem worth $8.04K as of Q2 2026.
  • Oakworth Capital left its Xylem share count unchanged in Q2 2026.
  • Xylem made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #719 holding.
  • Oakworth Capital first reported a position in Xylem in Q2 2016 and has held it in 10 quarters since.
  • Oakworth Capital's Xylem position peaked at $11.6K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.